Viatris Inc.

In News

J&J’s Invega Sustenna Patent Survives Teva, Viatris Appeals - Bloomberg Law News

Bloomberg Law News - Jul 08, 2025

Viatris Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141 in Presbyopia - PR Newswire

PR Newswire - Jun 26, 2025

Viatris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Financial Guidance - Viatris

Viatris - Feb 27, 2025

Fda discontinues Mylan Pharmaceuticals' potassium chloride tablet - MarketScreener

MarketScreener - Jul 08, 2025

Viatris agrees to pay up to $335M to settle opioid claims - Fierce Pharma

Fierce Pharma - Apr 07, 2025

Viatris (VTRS) Faces Securities Fraud Class Action Over FDA Inspection Fallout - Yahoo Finance

Yahoo Finance - Jun 06, 2025

VIATRIS INC. (NASDAQ: VTRS) SHAREHOLDER ALERT Bernstein - GlobeNewswire

GlobeNewswire - May 27, 2025

Viatris Deadline Today: Rosen Law Firm Urges Viatris Inc. (NASDAQ: VTRS) Stockholders With Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Business Wire - Jun 03, 2025

Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors - PR Newswire

PR Newswire - May 05, 2025

Viatris to Report Second Quarter 2025 Financial Results on August 7, 2025 - Yahoo Finance

Yahoo Finance - Jun 12, 2025

Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook - PR Newswire

PR Newswire - May 08, 2025

Viatris Inc. (VTRS): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential - Yahoo Finance

Yahoo Finance - Apr 27, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.